<?xml version="1.0"?><rdf:RDF xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:edm="http://www.europeana.eu/schemas/edm/" xmlns:wgs84_pos="http://www.w3.org/2003/01/geo/wgs84_pos" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:rdaGr2="http://rdvocab.info/ElementsGr2" xmlns:oai="http://www.openarchives.org/OAI/2.0/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:ore="http://www.openarchives.org/ore/terms/" xmlns:skos="http://www.w3.org/2004/02/skos/core#" xmlns:dcterms="http://purl.org/dc/terms/"><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:doc-OVK6JBDS/43f3f504-dce6-4825-9538-9fca8f9c0dcd/PDF"><dcterms:extent>144 KB</dcterms:extent></edm:WebResource><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:doc-OVK6JBDS/9f052f3c-bb28-4f5d-a750-070a194faefb/TEXT"><dcterms:extent>30 KB</dcterms:extent></edm:WebResource><edm:TimeSpan rdf:about="1994-2025"><edm:begin xml:lang="en">1994</edm:begin><edm:end xml:lang="en">2025</edm:end></edm:TimeSpan><edm:ProvidedCHO rdf:about="URN:NBN:SI:doc-OVK6JBDS"><dcterms:isPartOf rdf:resource="https://www.dlib.si/details/URN:NBN:SI:spr-46R7GGHL" /><dcterms:issued>2010</dcterms:issued><dc:creator>Skok, Pavel</dc:creator><dc:format xml:lang="sl">številka:4</dc:format><dc:format xml:lang="sl">letnik:49</dc:format><dc:format xml:lang="sl">str. 503-510</dc:format><dc:identifier>ISSN:0025-8121</dc:identifier><dc:identifier>COBISSID:3818815</dc:identifier><dc:identifier>URN:URN:NBN:SI:doc-OVK6JBDS</dc:identifier><dc:language>sl</dc:language><dc:publisher xml:lang="sl">Medicinski razgledi</dc:publisher><dcterms:isPartOf xml:lang="sl">Medicinski razgledi</dcterms:isPartOf><dc:subject xml:lang="en">Helicobacter Infections</dc:subject><dc:subject xml:lang="en">Helicobacter pylori</dc:subject><dc:subject xml:lang="en">Helicobacter, infekcije</dc:subject><dc:subject xml:lang="en">Peptic Ulcer</dc:subject><dc:subject xml:lang="sl">Peptični ulkus</dc:subject><dc:subject xml:lang="en">therapy</dc:subject><dc:subject xml:lang="sl">vnetja</dc:subject><dc:subject xml:lang="sl">Zdravljenje</dc:subject><dc:subject xml:lang="sl">želodec</dc:subject><dc:subject rdf:resource="http://www.wikidata.org/entity/Q180556" /><dcterms:temporal rdf:resource="1994-2025" /><dc:title xml:lang="sl">Peptična razjeda in okužba s Helicobacter pylori| Peptic ulcer and Helicobacter pylori infection|</dc:title><dc:description xml:lang="sl">Gastric and duodenal peptic ulcers are among the most frequent diseases of mankind. Etiological causes for deep gastric and duodenal mucosal lesions are heterogeneous, and among them Helicobacter pylori infection and the use of nonsteroidal-antiinflammatory drugs are most important. Infection with this bacterium is accepted as the main etiological factor for different disease of the upper digestive tract, including gastric cancer. The majority of countries, along with Slovenia, have accepted national guidelines for the treatment of this infection already a decade ago. The indications for its eradication are absolute and elective. Among absolute indications are gastric and duodenal ulcer disease, MALT lymphoma, atrophic gastritis and gastric cancer, while elective indications include functional dyspepsia, gastroesophageal reflux disease and treatment with nonsteroidal-antiinflammatory drugs. Triple antimicrobal therapies based on proton pump inhibitors and two antibiotics are accepted as the therapy of choice. The results of eradication therapies depend on the local Helicobacter pylori resistance rate to antibiotics and patient compliance. The article presents the causes of peptic ulcer, effects of H. pylori colonization of upper gastrointestinal tract mucosa, indications and the most commonly used drug combinations for its eradication</dc:description><dc:description xml:lang="sl">Peptična razjeda želodca in dvanajstnika sodita med najpogostejše bolezni človeštva. Vzroki nastanka globoke poškodbe sluznice so različni, med najpomembnejšimi je okužba s Helicobacter pylori in uporaba nesteroidnih protivnetnih zdravil. Okužba je pomemben etiološki dejavnik različnih bolezni zgornje prebavne cevi, tudi raka želodca. Prva priporočila za izkoreninjenje so bila sprejeta v večini držav in tudi v Sloveniji že pred dobrim desetletjem. Indikacije za zdravljenje so absolutne in relativne. Med absolutne sodijo peptična razjeda želodca ali dvanajstnika, limfom MALT, atrofični gastritis in želodčni rak. Med relativne indikacije sodijo funkcionalna dispepsija, gastroezofagealna refluksna bolezen in zdravljenje z nesteroidnimi protivnetnimi zdravili. Najučinkovitejša zdravila za izkoreninjenje okužbe so zaviralec protonske črpalke in kimbinacija dveh antibiotikov. Uspešnost zdravljenja okužbe je odvisna zlasti od odpornosti klice na uporabljena antibiotika in od bolnikovega sodelovanja. V prispevku so predstavljeni vzroki peptične razjede, posledice okužbe s Helicobacter pylori na sluznici zgornje prebavne cevi, indikacije in najpogostejše kombinacije zdravil za izkoreninjenje okužbe</dc:description><edm:type>TEXT</edm:type><dc:type xml:lang="sl">znanstveno časopisje</dc:type><dc:type xml:lang="en">journals</dc:type><dc:type rdf:resource="http://www.wikidata.org/entity/Q361785" /></edm:ProvidedCHO><ore:Aggregation rdf:about="http://www.dlib.si/?URN=URN:NBN:SI:doc-OVK6JBDS"><edm:aggregatedCHO rdf:resource="URN:NBN:SI:doc-OVK6JBDS" /><edm:isShownBy rdf:resource="http://www.dlib.si/stream/URN:NBN:SI:doc-OVK6JBDS/43f3f504-dce6-4825-9538-9fca8f9c0dcd/PDF" /><edm:rights rdf:resource="http://rightsstatements.org/vocab/InC/1.0/" /><edm:provider>Slovenian National E-content Aggregator</edm:provider><edm:intermediateProvider xml:lang="en">National and University Library of Slovenia</edm:intermediateProvider><edm:dataProvider xml:lang="sl">Društvo Medicinski razgledi</edm:dataProvider><edm:object rdf:resource="http://www.dlib.si/streamdb/URN:NBN:SI:doc-OVK6JBDS/maxi/edm" /><edm:isShownAt rdf:resource="http://www.dlib.si/details/URN:NBN:SI:doc-OVK6JBDS" /></ore:Aggregation></rdf:RDF>